0
Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¾ÆÆíÀ¯»çÁ¦¸¦ »ç¿ëÇÑ ¾ÏȯÀÚ¿¡¼­ ¹ß»ýÇÑ Åë°¢°ú¹Î 2·Ê

Two Cases of Opioid-Induced Hyperalgesia in Cancer Patients Treated with Opioids for Pain Management

Journal of Hospice and Palliative Care 2019³â 22±Ç 2È£ p.100 ~ 104
KMID : 0856920190220020100
È«¼®Ã¶ ( Hong Suk-Chul ) - °­µ¿¼º½Éº´¿ø ³»°ú

±ÇÁ¤Çý ( Kwon Jung-Hye ) - ÇѸ²´ëÇб³ Àǰú´ëÇÐ ³»°úÇб³½Ç
ÇѼöÁ¤ ( Han Su-Jung ) - °­µ¿¼º½Éº´¿ø ¿ÏÈ­ÀǷẴµ¿

Abstract

Opioids are important drugs for the management of severe cancer pain without a ceiling effect. However, opioid administration leads to dose-limiting complications including drowsiness, hallucinations, delirium, respiratory depression, cognitive impairment, seizure, myoclonus, and hyperalgesia. Opioid-induced hyperalgesia (OIH) is a paradoxical phenomenon as opioid exposure increases pain sensitivity. Reducing or stopping opioids, opioid rotation, or co-administration of N-methyl-D-aspartate (NMDA) antagonists have been suggested for the management of OIH. In this study, we report two clinical cases of successful management of OIH in cancer pain patients that were treated with opioids.
KeyWords

Neoplasms, Pain, Opioid analgesics, Hyperalgesia
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
  
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø